Radiographic progression-free survival as a response biomarker in metastatic castration-resistant prostate cancer: COU-AA-302 results Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Prostatic Neoplasms, Castration-Resistant

abstract

  • rPFS was highly consistent and highly associated with OS, providing initial prospective evidence on further developing rPFS as an intermediate end point in mCRPC trials.

publication date

  • April 20, 2015

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4881370

Digital Object Identifier (DOI)

  • 10.1200/JCO.2014.55.3875

PubMed ID

  • 25624432

Additional Document Info

start page

  • 1356

end page

  • 63

volume

  • 33

number

  • 12